Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : The Trump Presidency -- Ignore unavailable to you. Want to Upgrade?

To: i-node who wrote (64334)	4/3/2018 3:37:36 PM
From: TimF	1 Recommendation Recommended By i-node Respond to of 364481

I have no idea about Israel and its R&D funding but it is really cranking out some good stuff right now. To borrow a term that Obama overused when talking in a number of smaller countries (and some not so small, I think he used it in Poland) - They "punch above their weight". OTOH in terms of population they are are in a pretty light weight class. Similar population to Austria, Honduras, Virginia, or New York City (city only not metro). They may play a disproportionate part of medical R&D or total R&D, in terms of where it takes place or who does it, but would still play a smaller role than the UK, let alone the US. Even in terms of future growth I'd expect more of it from place like China and India than Israel. It takes an awful lot of "punching above your weight" for a country of 8+million to compare to countries approaching a billion and a half, and esp. to stay that we in the long run. In terms of incentivizing the R&D by providing a source of profitable sales of the drugs and other treatments there population and market size simply isn't there.